Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Retained Earnings (2024 - 2025)

Historic Retained Earnings for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$425.1 million.

  • Pyxis Oncology's Retained Earnings fell 2960.37% to -$425.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$425.1 million, marking a year-over-year decrease of 2960.37%. This contributed to the annual value of -$363.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Retained Earnings is -$425.1 million, which was down 2960.37% from -$403.1 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Retained Earnings registered a high of -$289.5 million during Q1 2024, and its lowest value of -$425.1 million during Q3 2025.